Ingo Helbig
- Psychiatry and Mental health top 1%
- Epilepsy research and treatment 49
- Genetics top 1%
- Genetics and Neurodevelopmental Disorders 53
- Genomics and Rare Diseases 50
- Genomic variations and chromosomal abnormalities 17
-
- Neuroscience and Neuropharmacology Research 12
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders 12
-
- Ion channel regulation and function 12
- RNA and protein synthesis mechanisms 9
- Co-authors
- Samuel F. BerkovicIngrid E. SchefferKatherine L. HelbigJohn C. MulleyAhmad Abou TayounDaniel H. LowensteinRikke S. MøllerHeather C. Mefford
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Ingo Helbig
112 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 121
- Psychiatry and Mental health 1.1k
- Genetics 1.3k
- Cellular and Molecular Neuroscience 648
- Clinical Biochemistry 188
- Pediatrics, Perinatology and Child Health 332
Countries citing papers authored by Ingo Helbig
This map shows the geographic impact of Ingo Helbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Helbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Helbig more than expected).
Fields of papers citing papers by Ingo Helbig
This network shows the impact of papers produced by Ingo Helbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Helbig. The network helps show where Ingo Helbig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ingo Helbig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 28 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 65 | |
| 15 | 2022 | 39 | |
| 16 | 2022 | 4 | |
| 17 | 2022 | 19 | |
| 18 | 2021 | 8 | |
| 19 | 2021 | 17 | |
| 20 | 2018 | 68 |
About Ingo Helbig
Ingo Helbig is a scholar working on Psychiatry and Mental health, Genetics and Clinical Biochemistry, having authored 124 papers that have together received 2.8k indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (53 papers), Genomics and Rare Diseases (50 papers), Epilepsy research and treatment (49 papers), Genomic variations and chromosomal abnormalities (17 papers), Metabolism and Genetic Disorders (12 papers), Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (12 papers) and RNA and protein synthesis mechanisms (9 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Genetics (1.3k citations) and Cellular and Molecular Neuroscience (648 citations). Ingo Helbig has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Samuel F. Berkovic, Ingrid E. Scheffer, Katherine L. Helbig, John C. Mulley, Ahmad Abou Tayoun, Daniel H. Lowenstein, Rikke S. Møller, Heather C. Mefford, Sha Tang and Deepali N. Shinde. Their work appears in journals such as Epilepsia, Neurology, Epilepsy Research, Genetics in Medicine and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.